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Many African countries, through their development plans, have ƉƌŝŽƌŝƟƐĞĚĂĐĐĞƐƐƚŽĂīŽƌĚĂďůĞ
healthcare services. However, the 
ƌĞĂůŝƐĂƟŽŶŽĨƚŚĞƐĞĂƐƉŝƌĂƟŽŶƐŚĂƐ
ďĞĞŶĐŽŶƐƚƌĂŝŶĞĚĚƵĞƚŽƚŚĞŚŝŐŚĐŽƐƚƐ




is important since up to 90% of the 
ƉŽƉƵůĂƟŽŶƉƵƌĐŚĂƐĞƐŵĞĚŝĐŝŶĞƐƚŚƌŽƵŐŚ
out-of-pocket payments.
As a result, many African countries 
ŚĂǀĞƐƚĂƌƚĞĚŝŶŝƟĂƟǀĞƐƚŽƉƌŽŵŽƚĞ
ůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůŵĂŶƵĨĂĐƚƵƌŝŶŐ͕
to address the issue of high costs 





transfer and enhancing intra-Africa trade.
dŚŝƐŚĂƐůĞĚƚŽƚŚĞĞƐƚĂďůŝƐŚŵĞŶƚŽĨ
ĂďŽƵƚϭϳϮůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůĮƌŵƐŝŶ
the Economic Community of West African 








chain (access to inputs, manufacturing, 
ĂŶĚŵĂƌŬĞƟŶŐͿ͘dŚĞƐĞŝŶĐůƵĚĞ͗




packaging materials, as well as other 
inputs that are not manufactured in the 
region.
;ďͿ^ŚŽƌƚĂŐĞŽĨƐŬŝůůĞĚůĂďŽƵƌͲƚŚĞ





This policy brief arises from a study 
commissioned by the Scinnovent 




















to address the human resource 
requirements for the sector in West 
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;ĐͿǆƉĞŶƐŝǀĞƉŚĂƌŵĂĐĞƵƟĐĂů
manufacturing equipment and 
ƚĞĐŚŶŽůŽŐŝĞƐͲƚŚĞďƵůŬŽĨƚŚĞ
ƉŚĂƌŵĂĐĞƵƟĐĂůŵĂŶƵĨĂĐƚƵƌŝŶŐ


















infrastructure, weak enforcement 
power, and inadequate human 
resource capacity, amongst others. 
The medicines regulatory sector is 
ĂůƐŽĨĂĐĞĚǁŝƚŚƚŚĞƉƌŽďůĞŵƐŽĨƉŽŽƌ
ŵŽƟǀĂƟŽŶĂŶĚůŽǁƌĞƚĞŶƟŽŶŽĨƐƚĂī͖
















all donor and development partners 
ĨƵŶĚĞĚƉƌŽĐƵƌĞŵĞŶƚŽĨĞƐƐĞŶƟĂů




the issue of inadequate human 
resources that can support the growth 
ŽĨůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůĮƌŵƐŝŶtĞƐƚ
ĨƌŝĐĂ͘/ƚĚŽĐƵŵĞŶƚƐƚŚĞĨŽůůŽǁŝŶŐ͗
a. The current human resource 
ƐŝƚƵĂƟŽŶŝŶƚŚĞƉŚĂƌŵĂĐĞƵƟĐĂůĮƌŵƐ
in each of the nine countries of West 





to address the human resources 
challenge.
c. The role the West African in the 




countries from Asian countries 
ĐĂŶŚĞůƉƚŽƐƵƉƉŽƌƚƚŚĞƐĞĐƚŽƌ͕ ďǇ
ĚŽĐƵŵĞŶƟŶŐƐƵĐĐĞƐƐƐƚŽƌŝĞƐĂŶĚ
lessons learned from other countries.
e. The extent countries in the region 
ǁŝƚŚŵŽƌĞĚĞǀĞůŽƉĞĚƉŚĂƌŵĂĐĞƵƟĐĂů
ƐĞĐƚŽƌ͕ ƐƵĐŚĂƐ͕EŝŐĞƌŝĂĂŶĚ'ŚĂŶĂĐĂŶ











consultants, who were contracted in 
ĞĂĐŚŽĨƚŚĞƐĞĐŽƵŶƚƌŝĞƐ͘/ŶĂĚĚŝƟŽŶ͕Ă



















reports that were moderated during a 









in West Africa is quite precarious. 
dŚĞƌĞŝƐĂŵŝǆƚƵƌĞŽĨƐŵĂůůƉƌŽƉŽƌƟŽŶ
ŽĨůŽĐĂůĂŶĚƉůĞŶƚǇŽĨ/ŶĚŝĂŶ
technologists manning the sector 
in the region. Companies in the 
ƉŚĂƌŵĂĐĞƵƟĐĂůŵĂŶƵĨĂĐƚƵƌŝŶŐƐĞĐƚŽƌ
ĂŶĚƚŚĞŝƌ/ŶĚŝĂŶƉĂƌƚŶĞƌƐŵŽƐƚůǇ
source for industrial pharmacists 
ĨƌŽŵ/ŶĚŝĂƵŶĚĞƌŝŶĚŝǀŝĚƵĂůĞīŽƌƚƐ͘
/Ŷ'ŚĂŶĂĨŽƌĞǆĂŵƉůĞ͕ƚŚĞƌĞĂƌĞ
ĂďŽƵƚϱϬ9 local pharmacists in the 
ŝŶĚƵƐƚƌǇƚŚĂƚĂĐĐŽƵŶƚĨŽƌŽŶůǇϭ͘ϵй








picture is found in Senegal, where 















is another great challenge facing the 
3
MANUFACTURER SHAREHOLDER TECHNICAL MANAGER TYPE OF FACTORY
''/ Togolese Togolese >ŽĐĂůƉƌŽĚƵĐƟŽŶ
KW,ZD Togolese /ŶĚŝĂŶƐ >ŽĐĂůƉƌŽĚƵĐƟŽŶ
^WZh<&/> /ŶĚŝĂŶƐ /ŶĚŝĂŶƐ >ŽĐĂůƉƌŽĚƵĐƟŽŶ




of medical personnel, pharmacists 
ŝŶĐůƵƐŝǀĞ͕ĞŵŝŐƌĂƟŶŐĨƌŽŵƐƵďͲ^ĂŚĂƌĂŶ
Africa revealed that many medical 







investment for these West African 
ĐŽƵŶƚƌŝĞƐŝƐĂůŵŽƐƚh^ΨϮ͘ϭϳďŶǁŚŝůĞ
the net gain for the developed 
countries to which they emigrated 
ǁĂƐƉůĂĐĞĚĂƚh^Ψϰ͘ϱϱďŶ;DŝůůƐ
ĞƚĂů͕͘ϮϬϭϭͿ͘&ŝŶĂůůǇ͕ ŵĂŶǇǇŽƵŶŐ











of the graduates from the local 
ŝŶƐƟƚƵƟŽŶƐƚŽƐƵƉƉŽƌƚƚŚĞƵŶŝƋƵĞ








are involved with the training of 
pharmacists, engineers and other 
ƐĐŝĞŶƟƐƚƐĨŽƌƚŚĞƐĞĐƚŽƌ͘ dŚĞƌĞĂƌĞ
ĂůƐŽƐŽŵĞŽƚŚĞƌƚƌĂŝŶŝŶŐŝŶƐƟƚƵƟŽŶƐ
that train technicians for the sector, 
including some of the polytechnics, 
ǁŚŝĐŚĂƌĞŶŽǁƵŶŝǀĞƌƐŝƟĞƐ͘
/ƚŝƐŽŶůǇ<Eh^dƚŚĂƚƚƌĂŝŶƐƚƵĚĞŶƚƐ






















Nigeria approved minimum standards 
ŽĨĮǀĞͲǇĞĂƌƚƌĂŝŶŝŶŐĐƵƌƌŝĐƵůƵŵĨŽƌ
WŚĂƌŵĂĐǇ͘ 







expanded to handle the challenges 


























not have a highly specialised training 
ƉƌŽŐƌĂŵŵĞĨŽƌƚŚĞƉŚĂƌŵĂĐĞƵƟĐĂů
industry. Those trained are not 
ƐƉĞĐŝĂůŝƐĞĚŝŶƚŚĞWŚĂƌŵĂĐĞƵƟĐĂů
/ŶĚƵƐƚƌǇĂŶĚƚŚĞƌĞĨŽƌĞƚŚĞƐĞĐƚŽƌ
is full of pharmacists with some 
ƵŶĚĞƌƐƚĂŶĚŝŶŐŝŶƉŚĂƌŵĂĐĞƵƟĐĂů
manufacturing acquired during 
ƚŚĞŝƌƵŶŝǀĞƌƐŝƚǇƚƌĂŝŶŝŶŐďƵƚĂƌĞŶŽƚ




the only university with a faculty 
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Common challenges to pharmacy 
training from all these countries 
ŝŶĐůƵĚĞ͗














diaspora in providing technical 
ƐƵƉƉŽƌƚƚŽƚŚĞůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂů
industries. This is mainly due to lack 
of a policy framework to engage them 
ĨŽƌƚŚĞƐĞĐƚŽƌ͘ &ŽƌĞǆĂŵƉůĞ͕ŝŶ'ŚĂŶĂ͕























diaspora also represents a pool of 






Secondly, apart from Nigeria and 
'ŚĂŶĂ͕ƚŚĞƌĞŵĂŝŶŝŶŐtĞƐƚĨƌŝĐĂŶ









Senegal are not numerous and 
ĐŽŶƐĞƋƵĞŶƚůǇƚŚĞŽīĞƌŝƐŵƵĐŚůŽǁĞƌ
than the demand. The industries 
ĂƌĞĂůƐŽŶŽƚĂƩƌĂĐƟǀĞŝŶƚĞƌŵƐŽĨ
ŝŶŶŽǀĂƟǀĞƉƌŽĚƵĐƚƐ͕ŝŶĨƌĂƐƚƌƵĐƚƵƌĞƐ
so that the Senegalese diaspora is 
ŶŽƚŝŶĐĞŶƟǀŝǌĞĚĞŶŽƵŐŚƚŽƌĞƚƵƌŶ




















Role of Asian Countries, 
Successes and Lessons Learnt
The Asian countries are key players 
ŝŶƚŚĞƉŚĂƌŵĂĐĞƵƟĐĂůŝŶĚƵƐƚƌŝĞƐŝŶ






of large imports of medicines into 
West Africa.
They are also the main sources of 
ƉŚĂƌŵĂĐĞƵƟĐĂůƉĂĐŬĂŐŝŶŐŵĂƚĞƌŝĂůƐ


















encouraged its companies to support 
ĨƌŝĐĂŶƉŚĂƌŵĂĐĞƵƟĐĂůƉƌŽĚƵĐƟŽŶ
to facilitate access to medicines 
ĞǆĐůƵƐŝǀĞůǇƚŽŝŶǀĞƐƚŵĞŶƚƉƌŽũĞĐƚƐŝŶ





However, with a strong win-win 
partnership and agreement their 
presence could promote the transfer 
ŽĨƚĞĐŚŶŽůŽŐǇ͕ ŐĞŶĞƌĂƚĞũŽďƐ͕ůŝŵŝƚ
imports and therefore facilitate access 
to medicines. Another opportunity for 
ĐŽůůĂďŽƌĂƟŽŶŝƐǁŚĞƌĞůŽĐĂůŝŶĚƵƐƚƌŝĞƐ
currently in Senegal could purchase 
ďƵůŬŐĞŶĞƌŝĐƉƌŽĚƵĐƚƐĨƌŽŵƚŚĞƐĞ
countries and make the secondary 
packaging.  
Đ͘/ŶdŽŐŽ͕ƐŝĂŶƚĞĐŚŶŝĐŝĂŶƐĂƌĞ
already working with manufacturers in 



















industries in ECOWAS, have the 
ƉŽƚĞŶƟĂůƚŽƐƵƉƉŽƌƚƚŚĞŽƚŚĞƌ
ĐŽƵŶƚƌŝĞƐŝŶƚĞƌŵƐŽĨĐĂƉĂĐŝƚǇďƵŝůĚŝŶŐ




documented to act as a learning 
curve for some countries that want to 
























to complement the training of 














from these industries to get WHO 
ĐĞƌƟĮĐĂƟŽŶƐ͘/ŶǀĞƐƟŶŐŝŶĚĞǀĞůŽƉŝŶŐ
the human resource required for 
ƚŚĞƐĞĐƚŽƌƐŚŽƵůĚďĞŐŝǀĞŶƉƌŝŽƌŝƚǇ͕ 







the nine countries. However, the 
ŐƌĂĚƵĂƚĞƐĨƌŽŵƚŚĞƐĞƵŶŝǀĞƌƐŝƟĞƐ
do not have the required skills 
ĂŶĚĞǆƉĞƌƟƐĞƚŽƉƌŽƉĞƌůǇĮƚŝŶƚŚĞ
ůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůŝŶĚƵƐƚƌŝĞƐ͕
due to inadequate exposure in 











the numerous pharmacy training 
schools to have their in-house mini 





key role in training pharmacists 
and pharmacy researchers who 
ĐĂŶƉŽƐƐĞƐƐƚŚĞƌĞƋƵŝƌĞĚĞǆƉĞƌƟƐĞ
and meet the demand of the 
ƉŚĂƌŵĂĐĞƵƟĐĂůŵĂƌŬĞƚŝŶƚŚĞKt^
region.
d. To improve on quality of graduate 
ƚŚĂƚŝƐĮƚĨŽƌƚŚĞƉŚĂƌŵĂĐĞƵƟĐĂů
ŝŶĚƵƐƚƌŝĞƐ͕ƵŶŝǀĞƌƐŝƟĞƐƐŚŽƵůĚ
periodically review their curricula to 









strengthened. Second, the regional 
ŚĂƌŵŽŶŝƐĂƟŽŶŽĨƚŚĞĐƵƌƌŝĐƵůĂŽĨ
ƚƌĂŝŶŝŶŐĨŽƌĮƌƐƚ͕ƐĞĐŽŶĚĂŶĚƚŚŝƌĚ
cycles of pharmacy studies would 
ůĞĂĚƚŽƚŚĞƉƌŽĚƵĐƟŽŶŽĨĂƋƵĂůŝĮĞĚ











long-term courses for regulators and 






provide a framework for engagement 
with the sector in terms of investment, 
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They are the main exporters of 
medicines to ECOWAS countries 
ĂŶĚƉŚĂƌŵĂĐĞƵƟĐĂůŝŶƉƵƚƐƚŽ
Kt^ůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂů
industries. Exploring partnerships and 
ĐŽůůĂďŽƌĂƟŽŶŽŶĐĂƉĂĐŝƚǇďƵŝůĚŝŶŐĂŶĚ
technology transfer that result into 
ǁŝŶͲǁŝŶƐŝƚƵĂƟŽŶŝƐƌĞĐŽŵŵĞŶĚĞĚ͘
ϱ͘ŽůůĂďŽƌĂƟŽŶǁŝƚŚŝŶKt^͗dŚĞ
study has shown that each of the 
nine countries has unique experience 
ƚŚĂƚƚŚĞǇĐĂŶŽīĞƌƚŽĞĂĐŚŽƚŚĞƌ
to support the development of the 
ůŽĐĂůƉŚĂƌŵĂĐĞƵƟĐĂůŝŶĚƵƐƚƌŝĞƐŝŶƚŚĞ
region. Through ECOWAS and WAHO, 
ĞīŽƌƚƐƐŚŽƵůĚďĞŐŝǀĞŶƚŽĚĞǀĞůŽƉŝŶŐĂ
framework that can facilitate this.
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